Fabio Zattoni
@Fabio_Zattoni
Followers
194
Following
250
Media
15
Statuses
81
Live now: #MDT Tumor Board Discussion on #Prostate #Cancer Top experts from surgery, oncology, radiology & radiation oncologist come together for evidence-based decision-making. Collaborative expertise at its finest! 😷💊 @UFalagario @Fabio_Zattoni @bernardorocco73 @vmollica7
0
2
3
Smarter staging in prostate cancer? 🙋🏼♂️🙋🏻♂️🙋🏾♂️In patients with intermediate/high-risk prostate cancer and negative PSMA PET (miN0), extended pelvic lymph node dissection (ePLND) remains a clinical dilemma. 🔍 This multi-institutional study (n = 282) externally validated five
1
23
61
🏆While TR-TBx has been the standard for years, TP-TBx minimizes infection risks and reduces the need for antibiotics, making it the gold medal choice for modern prostate cancer diagnostics! 📖 Read the full study! https://t.co/OiBGj1JzMD
#ProstateCancer #Urology #TPBx #TRBx
1
1
3
0
3
5
🚨Which is the ROLE of PLND in #ProstateCancer pts with NEGATIVE pre-op PSMA PET? 🧐 Help us find it out by taking part to a 5-min SURVEY! 👉 https://t.co/q2e6dqUWUR 🤳or use the QR Code 📢Your experience matters! @Uroweb @EAUYAUrology @SIU_Italia #UroSoMe
2
9
11
@pcan_journal TOP RESEARCH of 2024 AWARD ⭐️ Very proud of this recognition for our paper on enhanced #ProstateCancer detection by @Fabio_Zattoni Congrats to all Authors!
🌟 Editor-in-Chief Selection: Top Research of 2024 🌟 Explore groundbreaking studies in prostate cancer and prostatic diseases: 📌 Freedland et al.: Biochemical recurrence & PSA doubling time 📌 Zattoni et al.: mpMRI advancements 📌 Franco et al.: Single-port robotic
0
2
3
External validation of nomograms for predicting lymph node invasion (LNI) in prostate cancer patients with negative PSMA PET-CT. What did we find? The Briganti 2023 nomogram is the most accurate! 📊✅ 🔍 Why does it matter? Extended pelvic lymph node dissection (ePLND) is the
4
49
131
🌟 Editor-in-Chief Selection: Top Research of 2024 🌟 Explore groundbreaking studies in prostate cancer and prostatic diseases: 📌 Freedland et al.: Biochemical recurrence & PSA doubling time 📌 Zattoni et al.: mpMRI advancements 📌 Franco et al.: Single-port robotic
1
6
10
🔍Our study reveals that tailored follow-up strategies improve detection of #csPca in patients with positive mpMRI but negative Tbx and Systematic biopsy. Group-based follow-ups impact csPca free survival rates
0
4
14
EAU-EANM- ESTRO -ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent out on @EUplatinum
https://t.co/FWSSa11Pme The 2024 European Association of Urology @Uroweb guidelines on clinically localized
europeanurology.com
The evidence in the field of diagnosis, staging, and treatment of localised prostate cancer (PCa) is evolving rapidly. The 2024 European Association of Urology (EAU)-European Association of Nuclear...
1
34
88
🚨Do not miss latest findings on TP vs TR MRI-🎯Bx for #prostatecancer detection 👇🏻 @EurUrolOncol
https://t.co/R6aZoVbwQf
@Uroweb @EAUYAUrology
pubmed.ncbi.nlm.nih.gov
There were no significant differences in the prostate biopsy approaches (transperineal [TP] vs transrectal [TR]) for prostate cancer detection and complications. However, the MRI-targeted TP prostate...
TP-Tbx and TR-Tbx prostate biopsy have🟰csPca detection rates and🟰complication rates. #TPbiopsies can be safely performed without antibiotics, potentially reducing antibiotic resistance. https://t.co/HjXc8AjV08
0
6
8
TP-Tbx and TR-Tbx prostate biopsy have🟰csPca detection rates and🟰complication rates. #TPbiopsies can be safely performed without antibiotics, potentially reducing antibiotic resistance. https://t.co/HjXc8AjV08
0
9
23
Optimizing the number of MRI🎯Bx cores for enhanced #prostatecancer detection Read to find out a multifaceted approach tailored to individual characteristics of each 🌰 👇🏻 @EurUrolOpen
https://t.co/yyBSw2smI6 Kudos to @Fabio_Zattoni for leading this project! @EAUYAUrology
0
5
11
📢 PSMA PET/CT's accuracy in initial #PCa staging 🔍PSMA PET/CT has great accuracy in #SVI & #LNI detection. Still too many gaps in T-stage, EPE & distant metastasis detection➡️ more research needed! Our SR&MA just published in @pcan_journal ➡️ https://t.co/g8egGAkAj4
1
9
21
Articles in Press: Potential Applications of New Headsets for Virtual and Augmented Reality in Urology https://t.co/PB1aa5jcK7
@Fabio_Zattoni @giacomonovara @fabriziodalmoro
#UroSoMe #MedTwitter
0
3
6
Exciting times in healthcare!🚀 Imagine the possibilities with new VR/AR headsets in Urology! @Uroweb #HealthTech #VR #AR #MedicalInnovation @Apple @Meta @tim_cook @fabriziodalmoro @giacomonovara
eu-focus.europeanurology.com
Medical enhanced virtual reality/augmented reality has significant potential in urology. Application in preoperative planning, intraoperative support, and surgical education could revolutionize...
0
1
3
MMISU2023 Congress: Three Days of Top-Level Training and Collaboration! Yesterday and today, we attended the MMISU2023 international congress in Alexandria, Egypt. A unique opportunity to collaborate with the world's leading experts in urology and minimally invasive surgery. On
1
1
6
Great to be back in France 🇫🇷 after @FocusMeeting for the @EAUYAUrology @EAU_YAUProstate group meeting @Uroweb #EMUC23
0
2
26
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on PSMA-PET @EAU_YAUProstate @EAUYAUrology
https://t.co/NlogXlJYcU
1
44
129
Persistent PIRADS ≥ 3 at the 2nd MRI is suggestive of the presence of not negligible proportion of clinically significant #prostatecancer These findings contribute to the refinement of risk stratification for 👴🏼 with initial negative MRI-TBx https://t.co/DsOQO17tgv
@EAUYAUrology
5
34
106